Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus versus Sunitinib in metastatic non-clear cell renal carcinoma
2009-010143-13Phase 2Terminated
- Sponsor
- Central European Society for Anticancer Drug Research
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in non-clear cell renal cell carcinoma (nccRCC) and metastatic renal cell carcinoma (mRCC) comparing Temsirolimus arm with Sunitinib arm (2 arms). Primary endpoint: progression_free_survival. Started Apr 2009; status: terminated.
02
Drugs
temsirolimussunitinib
03
Conditions
non-clear cell renal cell carcinoma (nccRCC)metastatic renal cell carcinoma (mRCC)
Beyond the preview
Go deeper on 2009-010143-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010143-13.